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Abstract
Background
Mitochondrial DNA (mtDNA) copy number decreases in animal and human heart failure
(HF), yet its role in cardiomyocytes remains to be elucidated. Thus, we investigated the car-
dioprotective function of increased mtDNA copy number resulting from the overexpression
of human transcription factor A of mitochondria (TFAM) or Twinkle helicase in volume over-
load (VO)-induced HF.
Methods and Results
Two strains of transgenic (TG) mice, one overexpressing TFAM and the other overexpres-
sing Twinkle helicase, exhibit an approximately 2-fold equivalent increase in mtDNA copy
number in heart. These TGmice display similar attenuations in eccentric hypertrophy and
improved cardiac function compared to wild-type (WT) mice without any deterioration of mi-
tochondrial enzymatic activities in response to VO, which was accompanied by a reduction
in matrix-metalloproteinase (MMP) activity and reactive oxygen species after 8 weeks of
VO. Moreover, acute VO-induced MMP-2 and MMP-9 upregulation was also suppressed at
24 h in both TG mice. In isolated rat cardiomyocytes, mitochondrial reactive oxygen species
(mitoROS) upregulated MMP-2 and MMP-9 expression, and human TFAM (hTFAM) over-
expression suppressed mitoROS and their upregulation. Additionally, mitoROS were equal-
ly suppressed in H9c2 rat cardiomyoblasts that overexpress hTFAM or rat Twinkle, both of
which exhibit increased mtDNA copy number. Furthermore, mitoROS and mitochondrial
protein oxidation from both TG mice were suppressed compared to WT mice.
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Conclusions
The overexpression of TFAM or Twinkle results in increased mtDNA copy number and facil-
itates cardioprotection associated with limited mitochondrial oxidative stress. Our findings
suggest that increasing mtDNA copy number could be a useful therapeutic strategy to target
mitoROS in HF.
Introduction
Heart failure (HF) continues to be an unsolved problem in developed countries.[1] During HF,
hemodynamic load and neuro-hormonal activation cause structural and functional alterations
of the heart, which start initially as adaptive responses, but later become maladaptive, and
eventually lead to the vicious cycle of HF.[2] In the myocardium, mitochondria are not only a
critical source of adenosine tri-phosphate (ATP) but also produce reactive oxygen species
(ROS). Many study groups, including ours, have shown that mitochondrial ROS (mitoROS)
elicit mitochondrial DNA (mtDNA) damage and impair mitochondrial electron transport
chain (ETC) activity, resulting in additional mitoROS production. Notably, the presence of ex-
cess mitoROS is associated with maladaptive cardiac remodeling and HF progression in experi-
mental animal models.[3–7]
Mitochondrial transcription factor A (TFAM), which was initially cloned as an mtDNA
transcription factor, also plays an essential role in the maintenance of mtDNA and mitochon-
drial homeostasis.[8,9] Heart-specific TFAM knockout mice present with a critical depletion in
mtDNA copy number, progressive respiratory chain deficiency in the myocardium, and lethali-
ty due to severe cardiac dysfunction.[10,11] In contrast, TFAM overexpression increases
mtDNA copy number, ameliorates cardiac remodeling, and improves the survival after myo-
cardial infarction (MI) in mice.[12] However, the precise roles and the protective mechanisms
of mtDNA quantity in HF remain to be elucidated.
To examine the effect of increased mtDNA copy number on cardioprotection, we used
transgenic (TG) mice that overexpress TFAM (TFAMmice) or Twinkle (Twinkle mice). Twin-
kle is a nuclear DNA-encoded mitochondrial DNA helicase that exhibits structural similarity
to T7 phage helicase/primase, and is associated with heritable neuromuscular mitochondrial
disease.[13] TFAM increases mtDNA stability and the proportion of non-replicating nucleoids,
whereas Twinkle enhances mtDNA replication.[14] Despite acting through different mecha-
nisms, overexpression of either Twinkle or TFAM in mice increases mtDNA copy number
in mice.
We recently demonstrated that recombinant human TFAM (rhTFAM) suppresses angio-
tensin-induced hypertrophy in myocytes;, which have no deterioration of mtDNA transcrip-
tion or translation[15]; this suggests that TFAM overexpression and/or the associated increase
in mtDNA copy number might impart cardioprotective effects on cardiomyocytes in the ab-
sence of mtDNA depletion and mitochondrial dysfunction. In our preliminary experiments,
involving some HF mouse models, no significant mtDNA depletion and mitochondrial dys-
function were observed in VO-induced HF model. In this study, we thus investigated the
mechanistic effects of increasing mtDNA copy number by the overexpression of TFAM or
Twinkle on eccentric hypertrophy and extracellular matrix reconstruction in VO-induced HF
in TFAM- and Twinkle-overexpressing mice.
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Materials and Methods
TGmice and animal model of HF
All procedures and animal care were approved by the Committee on Ethics of Animal Experi-
ment for the Graduate School of Medical and Pharmaceutical Sciences at Kyushu University,
and were performed in accordance with the Guidelines for Animal Experiment of Kyushu Uni-
versity (A24–125) and the Guidelines for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH, 8th edition, revised in 2011). TG mice overex-
pressing either human TFAM[12] or murine Twinkle[14,16] under control of β-actin promoter
have been described previously. C57BL/6J mice were purchased from Kyudo, Japan. The VO
HF model was produced by creating an arteriovenous fistula (AVF) using an established proto-
col.[17] Briefly, 8- to 10 week-old male mice were anesthetized with a mixture of medetomi-
dine (0.3 mg/kg; Wako Chemicals), midazolam (4 mg/kg; Wako Chemicals), and butorphanol
tartrate (5 mg/kg; Wako Chemicals) by intraperitoneal administration according to institution-
al recommendation. AVFs were created by puncturing the wall separating the aorta and inferi-
or vena cava with a 22-gauge needle. The aorta was clamped superior to the perforation, and
the arterial hole was then sealed with cyanoacrylate. AVFs were confirmed by the presence of
red oxygenated arterial blood in the vena cava both during the procedure and at sacrifice. Con-
trol mice received sham operation without AVF creation. Mice were housed in a temperature-
and humidity-controlled room and provided with a commercial diet and water ad libitum.
Echocardiographic and hemodynamic measurements
Under light anesthesia with 1–2% isoflurane, two-dimensional targeted M-mode images were
obtained from the short-axis view at the level of papillary muscles by ultrasonography
(Vevo2100; VisualSonics). Hemodynamics were measured under anesthesia with tribro-
moethanol/amylene hydrate (Sigma) by intraperitoneal administration prior to sacrifice, at
which point a 1.4 F micromanometer-tipped catheter (Millar Instruments, Inc.) was inserted
into the right carotid artery and advanced into the left ventricle (LV) for pressure measure-
ment. After these measurements, mice were euthanized by an overdose of pentobarbital sodi-
um (40 mg/kg; Kyoritsu Seiyaku), and then their hearts and lungs were excised.
Western blot analyses
Frozen samples were homogenized in RIPA lysis buffer (Thermo Scientific). Mitochondria ly-
sates in RIPA lysis buffer were prepared from the isolated mitochondria derived from heart by
centrifugation for western blot analyses of nitrotyrosine and Complex II as an internal control.
Equal amounts of protein were then separated on SDS-PAGE and transferred to nitrocellulose
membranes. After blocking for 1 h with 5% skim milk in PBS, membranes were incubated with
primary antibody at 4°C overnight, followed by incubation with secondary antibody. Primary
antibodies used in this study are as follows: Human TFAM (custom made), murine TFAM (sc-
23588, Santa Cruz), glutathione peroxidase (ab16798, Abcam), Mn-SOD (sc-18503, Santa
Cruz), GAPDH (sc-32233, Santa Cruz), Flag (#2368, Cell Signaling Technology), Complex I
(#459100, Invitrogen), Complex II (#459200, Invitrogen), Complex IV (#459600, Invitrogen),
nitro-tyrosine (Millipore, AB5411).
Quantitative real-time polymerase chain reaction analyses
Total DNA and RNA were extracted by standard phenol-chloroform method or RNeasy tissue
kit (Qiagen), respectively. Total DNA was treated with MluI (Takara) for mouse mtDNA or
BamHI (Takara) for rat mtDNA for 2 h, and the relative amount of mtDNA was quantified by
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real-time PCR. The antithrombin III (AT III) gene was amplified to estimate the amount of ge-
nomic DNA as an internal control. Total RNA was converted to cDNA, and then quantified.
PCR mixtures contained 10 ng cDNA and 12 pmol of each primer in a total reaction volume of
30 μL. Ribosomal 18S rRNA was used as an internal control. The primer sequences are shown
in S1 Table.
Measurement of mitochondrial enzymatic activity
Mitochondria were isolated from myocardium using a sucrose gradient and mitochondrial
enzymatic activities were measured as described previously.[12] The enzymatic activity of ro-
tenone-sensitive NADH-dehydrogenase (Complex I) was measured by the reduction of
decylubiquinone, a ubiquinone analogue. Succinate dehydrogenase (Complex II) enzymatic
activity was assessed by the reduction of 2, 6-dichlorophenolindophenol. Coenzyme Q–
cytochrome c reductase (Complex III) activity was measured by the reduction of catalyzed
cytochrome c catalyzed in the presence of reduced decylubiquinone. Cytochrome c oxidase
(Complex IV) activity was assessed by the oxidation of reduced cytochrome c in the presence
of dithionite.
In situ zymography
In situ zymography was performed on heart tissue samples by using EnzChek Gelatinase/
Collagenase Assay Kit (Invitrogen). Briefly, frozen samples in OCT compound were sectioned
at 5 μm and air-dried for 30 min. Then, these samples were mounted with PBS or 1.10. phenan-
throline monohydrate (10 mmol/L, Sigma p9375) in PBS (used as a negative control) and incu-
bated for 1 h. Next, the samples were washed with PBS, mounted with DQ gelatin (50 μg/mL)
and incubated for 3 h in the dark condition. After incubation, the samples were washed and ob-
served under fluorescence microscopy (Olympus IX71; absorption, 495 nm; emission, 515 nm).
Ex vivo evaluation for ROS using dihydroethidium (DHE)
ROS levels in the heart tissue samples were evaluated ex vivo using a modified version of a pre-
viously described method.[5,18] Briefly, frozen tissue samples embedded in OCT compound
were sectioned at 10 μm, mounted with 100 μmol/L DHE in PBS and incubated at 37°C for
5 min. Thereafter, the sectioned samples were washed with PBS, fixed with 3% paraformalde-
hyde at room temperature for 15 min and then washed with PBS again. The washed sectioned
samples were then sealed with FluorSave Reagent (Vector Labolatories, H-1000) and observed
by fluorescence microscopy (Olympus IX71; absorption, 559 nm, emission, 570 nm).
Neonatal rat ventricular myocytes isolation and adenovirus vectors
harboring human TFAM
Neonatal rat ventricular myocytes were isolated and cultured as previously described.[15]
Briefly, neonatal rats were euthanized by an overdose of isoflurane (3–5%), and then hearts
were rapidly excised and digested. After digestion of the myocardial tissue with trypsin (Wako)
and collagenase type 2 (Worthington), cells were suspended in Dulbecco’s Modified Eagle’s
Medium (Sigma-Aldrich) containing 10% fetal bovine serum (FBS, Thermo Scientific), penicil-
lin (Invitrogen) and streptomycin (Invitrogen). Cells were plated twice in 100 mm culture
dishes for 70 min each to reduce the number of non-myocytes. Non-adherent cells were plated
in culture dishes (Primaria, Falcon). The replication-deficient recombinant adenoviral vector
containing hTFAM (AxCAhTFAM) was constructed using the Dual Version Adenovirus Ex-
pression Vector Kit from Takara. Adenoviruses were amplified in human embryonic kidney
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cell line (HEK-293), purified with the Adeno-X Maxi Purification Kit (Clontech), and then ti-
trated with the Adeno-X Rapid Titer kit (Clontech). The viral infection efficiency was>95%,
as measured by β-gal staining.
Complex I-mediated ROS production and resultant gene expression in
isolated myocytes
Isolated myocytes were treated with 1 μmol/L rotenone (R8875; Sigma) and incubated for 30
min. After washing with PBS, myocytes were treated with 1 μmol/L DHE, and incubated at
37°C for 10 min. For mRNA analysis, isolated myocytes were treated with 200 nmol/L rote-
none for 48 h.
H9c2 transfection with human TFAM or rat Twinkle-FLAG
The pCMV-hTFAM or pCMV-rTwinkle-FLAG expression vectors were linearized by AseI di-
gestion and transfected into H9c2 rat cardiomyoblasts with Lipofectamine 2000 (Life Technol-
ogies). Transfected cells were isolated by G-418 (Nacalai Tesque) selection.
Complex III-mediated ROS production in H9c2 cell lines
Antimycin A-induced mitoROS production was examined by MitoSOX Red (Molecular
Probes) in H9c2 cells as previously described.[19] Briefly, cells were incubated with 5 μmol/L
MitoSOX in HBSS containing Ca2+/Mg2+ for 30 min, washed once, and then treated with
100 μmol/L antimycin A (Sigma, A8674) in HBSS for 30 min.
In vitro ROS assay using mitochondria isolated from myocardium
Isolated mitochondria (160 μg/mL) were mixed with 50 mmol/L phosphate buffer, 20 mmol/L
succinate, 2 μg/mL antimycin A, and 10 μMNBD-Me-TPP, a fluorescent nitroxide switch.
[20,21] Fluorescence intensity was measured continuously for 2 min, and the slope defined the
rate of free radicals released from mitochondria.
Statistical Analysis
All data are expressed as mean ± SEM. Multiple groups are compared by one-way ANOVA fol-
lowed by post-hoc Tukey’s comparison test. Two groups were compared by unpaired Student’s
t-test.
Additional methods are available in S1 Text.
Results
Characterization of TFAMmice and Twinkle mice
TGmice overexpressing human TFAM (hTFAM) under control of the β-actin promoter have
been described previously.[12] The utilized model VO HF results from an AVF created in the
abdominal aorta. As such, we examined hTFAM expression in the aorta of TFAMmice and
confirmed a markedly lower expression in the aorta than in the heart (Fig. 1A). Due to the lack
of an available Twinkle antibody, we analyzed the transcription of Twinkle in the heart and
aorta by real-time PCR, and found an approximately 50-fold increase in the hearts of TG mice
as compared to wild-type (WT) mice, without a significant increase in the aorta (S1A Fig.).
mtDNA copy number in hearts increased 2.3- and 2.1-fold in TFAMmice and Twinkle mice,
respectively, when compared to WT littermates (Fig. 1B); however, no differences in mtDNA
copy number were observed in the aortas of TG andWTmice (S1B Fig.). It has been suggested
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that TFAM expression levels might correlate closely with mtDNA copy number.[22] As such,
we compared the expression of endogenous murine TFAM (mTFAM) in the TG mice, and
found that endogenous mTFAM was equally expressed in the TG mice compared to WT mice
in each strain (Fig. 1C). We further examined the transcription of mtDNA-encoded genes in
both TG mouse strains relative to WT mice (Fig. 1D). Notably, mtDNA-encoded gene tran-
scription was suppressed in TFAMmice when compared to WT mice. This result may be ex-
plained by two possibilities: (1) hTFAM is unable to mediate the transcription of murine
mtDNA-encoded genes, or (2) TFAM overexpression results in the overpackaging of mtDNA
and/or D-loop due the increased TFAM/mtDNA ratio.[23] In contrast, Twinkle mice exhibit a
variation in mtDNA-encoded gene expression, as some genes were upregulated while others
were unchanged or slightly downregulated compared to WT mice. This suggests that mtDNA
transcription varies between TFAM and Twinkle mice. Interestingly, despite this disparity, no
Fig 1. Characterization of TFAM and Twinkle (TW) mice. (A) Expression of human TFAM (hTFAM) in left ventricle (LV) and aorta in TFAM and wild-type
(WT) control mice. (B) mtDNA copy number in myocardium from TFAM and TWmice by real-time PCR (n = 4). (C) Expression of endogenous murine TFAM
(mTFAM) and mitochondrial complex proteins in LV of TFAM and TWmice. (D) Transcription of mtDNA-encoded genes in TFAM and TWmice (n = 6). Data
are expressed as mean ± SEM. *P< 0.05 vs. WT, **P< 0.01 vs. WT, analyzed by Student’s t-test.
doi:10.1371/journal.pone.0119687.g001
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differences in mitochondrial protein expression were observed (Fig. 1C). In addition, it was
previously reported that the ETC enzymatic activities in both TG mice are the same as WT
mice.[12,24] These findings demonstrate that neither hTFAM nor Twinkle overexpression bol-
sters mitochondrial activity at the translational and functional levels, despite the commonality
of increased mtDNA copy number in TFAM and Twinkle mice.
Overexpression of hTFAM or Twinkle equally attenuates eccentric
hypertrophy and improves cardiac function under VO
We first examined the effects of TFAM- or Twinkle overexpression on LV remodeling at 8
weeks after the AVF procedure. Hemodynamic stress in VO increased the heart mass by ap-
proximately 1.6–1.7 fold in WT mice,[25] whereas this observation was attenuated in TFAM
and Twinkle mice (Fig. 2A). Echocardiographic images showed severe LV dilatation and dys-
function in WTmice under VO, which were also ameliorated in both TG mice (Fig. 2B, S2
Table). In addition, VO-induced pulmonary congestion, characterized by increased lung mass
and left ventricular end-diastolic pressure (LVEDP), was improved in both TG strains com-
pared to WT (Fig. 2C, S3 Table). Histologically, Masson trichrome staining revealed that VO-
induced perivascular fibrosis was also suppressed in both TGmice (Fig. 2D, S2A Fig.), although
no significant alterations in cross-sectional area were detectable (S2B Fig.). These results vali-
date the major finding that the overexpression of hTFAM or Twinkle attenuates VO-induced
eccentric hypertrophy and improves cardiac function to a similar extent with an increase of
mtDNA copy number.
Mitochondrial characteristics in VO-induced myocardial hypertrophy
We previously identified that mtDNA copy number decreased approximately 40% in the fail-
ing myocardium of post-MI mice, whereas ETC enzymatic activities are only impaired in WT
mice after MI.[12] In this study, mtDNA copy number decreased approximately 25% in the hy-
pertrophied myocardium of WTmice 8 weeks after AVF formation (Fig. 2E), but no significant
impairments in ETC enzymatic activities were identified in TG or WT mice (Fig. 2F). These re-
sults suggest that preservation of ETC enzymatic activities is not the primary mechanism by
which hTFAM or Twinkle overexpression ameliorates eccentric hypertrophy.
Activation of in situ zymography: matrix metalloproteinase (MMP)
activity under VO is suppressed in TFAM and Twinkle mice
Many lines of evidence have established that MMPs harboring gelatinase activity, such as
MMP-2 and MMP-9, facilitate the progression of VO-induced HF by degrading extracellular
matrix.[26–30] As such, we examined MMP gelatinase activity in left ventricle by in situ zymo-
graphy in both TFAM and Twinkle mice. Notably, basal MMP gelatinase activity was observed
in WT mice under VO; however, this was suppressed in TFAM and Twinkle mice (Fig. 3A).
Since both MMP-2 and MMP-9 function as redox-sensitive signals at the transcriptional and
posttranslational levels,[26] we also examined ROS production in left ventricle using the fluo-
rescence superoxide probe, dihydroethidium (DHE). Significantly, higher levels of ROS were
detected in the failing myocardium of WT mice, but not TG mice (Fig. 3B). There results indi-
cate that TFAM and Twinkle TG mice have alterations in VO-induced myocardial MMPs ex-
pression and ROS production.
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Fig 2. Analysis of TFAM and Twinkle (TW) mice 8 weeks after arteriovenous fistula creation. (A) Heart
weight/body weight (HW/BW) (n = 12) (B) M-mode echocardiogram (C) Lung weight/body weight (LW/BW) in
TFAM and TWmice (n = 12). (D) Quantification of perivascular fibrosis standardized by vascular
circumference (n = 6). (E) mtDNA copy number in left ventricle (LV) of TFAM (upper panel) and TW (lower
panel) mice (n = 6). (F) Mitochondrial electron transport chain enzymatic activities in TFAM (upper panel) and
TW (lower panel) mice (n = 4–5). Data are expressed as mean ± SEM. *P< 0.05 vs. WT + Sham, **P< 0.01
vs. WT + Sham, †P< 0.01 vs. WT + VO, ††P< 0.01 vs. WT + VO, analyzed by one-way ANOVA followed by
post hoc Tukey’s test.
doi:10.1371/journal.pone.0119687.g002
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Fig 3. Matrix-metalloproteinase (MMP) gelatinase activity and reactive oxygen species (ROS)
production in the heart tissues of TFAMmice and Twinkle (TW) mice at 8weeks after creating
arteriovenous fistula. (A) Representative images and quantification of MMP gelatinase activities in LV from
TFAM or TWmice at 8 weeks after creating AVF (n = 6), **P< 0.01 vs. WT+Sham, †P< 0.01 vs. WT+VO,
††P< 0.01 vs. WT+VO, analyzed by one-way ANOVA followed by post hoc Tukey’s test. (B) Representative
images and quantification of Dihydroethidium staining (DHE) staining of LV from TFAM or TWmice (n = 6),
**P< 0.01 vs. WT+Sham, †P< 0.01 vs. WT+VO, ††P< 0.01 vs. WT+VO, analyzed by one-way ANOVA
followed by post hoc Tukey’s test. Scale bar, 100μm. All data are mean±SEM.
doi:10.1371/journal.pone.0119687.g003
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MMP-2 and MMP-9 mRNA upregulation in acute VO is suppressed in
TFAM and Twinkle mice
The above results support that hTFAM or Twinkle overexpression attenuates eccentric hy-
pertrophy and improves cardiac function under VO independent of mitochondrial ETC en-
zymatic activities despite of an increase in mtDNA copy number. Thus, we hypothesized that
the overexpression of TFAM or Twinkle is sufficient to suppress the molecular signals in-
volved in cardiac remodeling without any associated structural or functional deterioration in
the heart and mitochondria. To characterize the gene transcription during the acute phase of
VO, we first examined MMP-2 and MMP-9 expression 24 h after AVF creation. LVEDP sig-
nificantly elevated in mice under VO. (Fig. 4A). Notably, MMP-2 and MMP-9 expression
were significantly upregulated after 24 h of VO compared to Sham controls (Fig. 4B). We
next examined the effect of increased mtDNA copy number on MMP-2 and MMP-9 upregu-
lation after 24 h of VO. While no differences in LVEDP were observed between WT and TG
mice after AVF creation (Fig. 4C), both MMP-2 and MMP-9 were significantly hindered in
TG as compared to WT mice under VO (Fig. 4D). Additionally, TFAM or Twinkle overex-
pression also attenuated the upregulation of other VO-induced genes, including tissue inhibi-
tors of metalloproteinase (TIMP) family members and connective tissue growth factor
(CTGF) (Fig. 4B, D).
TFAM overexpression suppresses mitoROS and the mitoROS-induced
upregulation of MMP-2 and MMP-9 in cardiomyocytes
While our examination revealed that the overexpression of hTFAM or Twinkle suppresses
VO-induced gene expression to mitigate HF, the underlying mechanism remains unclear. In
the heart, the expression of MMPs are regulated through various signals including endogenous
hormones, cytokines, mechanical stretch, and ROS.[26] Mechanical stretch is a main mediator
of VO-induced MMP upregulation; however, a significant decrease in MMP expression was
observed in both TFAM and Twinkle mice with similar LVEDP. As such, we hypothesized that
reduction of mitoROS mainly contributes to the modulation of MMP transcription in both TG
mice, based on our previous observation that TFAM overexpression in HeLa cell suppresses
mitoROS.[31] To investigate the mechanism underlying the regulation of MMP-2 or MMP-9
expression by mitoROS, and to determine its dependency on TFAM overexpression, we over-
expressed human TFAM in isolated rat neonatal cardiomyocytes using an adenoviral vector
(Fig. 5A). As expected, hTFAM overexpression increased mtDNA copy number approximately
1.5-fold at 72 h after adenoviral infection (MOI = 1) (Fig. 5B), and inhibited the production of
mitoROS following treatment with rotenone, a specific inhibitor of complex I (Fig. 5C). Addi-
tionally, rotenone-induced mitoROS elicited the upregulation of MMP-2 and MMP-9 in cardi-
omyocytes, whereas this effect was suppressed by hTFAM overexpression (Fig. 5D). These
results suggest that MMP-2 and MMP-9 are regulated by mitoROS in cardiomyocytes, and
that hTFAM overexpression limits the production of mitoROS, suppressing MMP-2 and
MMP-9 expression.
TFAM or Twinkle overexpression suppresses antimycin A-induced
mitoROS in H9c2 cells
To examine the role of mtDNA copy number in the reduction of mitoROS, we generated H9c2
rat cardiomyoblasts that overexpress hTFAM or FLAG-tagged rat Twinkle (rTwinkle). Overex-
pression of hTFAM or rTwinkle was confirmed by western blot analysis (Fig. 6A), and was ac-
companied by a significant increase in mtDNA copy number (Fig. 6B). We used these cell lines
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to investigate the effect of increased mtDNA copy number on the production of mitoROS in-
duced by antimycin A, a specific inhibitor of mitochondrial complex III. As expected, mitoROS
were equally suppressed in H9c2 cells overexpressing hTFAM or rTwinkle compared to control
cells (Fig. 6C).
Fig 4. Volume overload (VO)-induced hemodynamic load andmRNA expression of matrix-
metalloproteinase (MMP)-2, MMP-9 and other VO-upregulated molecules in TFAM and Twinkle (TW)
mice at 24 hours after creating arteriovenous fistula. (A) Left ventricular end diastolic pressure (LVEDP)
in C57BL/6J mice after 24 h of volume overload (VO) (n = 4). (B) VO-induced mRNA expression of MMP-2,
MMP-9, connective tissue growth factor (CTGF), tissue inhibitor of metalloprotease (TIMP)-1,TIMP-2, TIMP-
3, and TIMP-4 in the hearts of C57BL/6J mice, as measured by real-time PCR (n = 4) at 24 h of VO (n = 4).
(C) Comparison of LVEDP in WT and transgenic (TG) mice at 24 h after VO creation (n = 6–12). (D) mRNA
expression of MMP-2, MMP-9, CTGF, TIMP-1, TIMP-3, and TIMP-4 in the hearts of WT and TGmice under
VO, as measured by real-time PCR (n = 6–12). Data are expressed as mean ± SEM. *P< 0.05 vs. Sham,
**P< 0.01 vs. Sham, †P< 0.01 vs. WT + VO, ††P< 0.01 vs. WT + VO, analyzed by Student’s t-test.
doi:10.1371/journal.pone.0119687.g004
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Fig 5. Effect of TFAM overexpression onmitochondrial DNA (mtDNA), mitoROS andmRNA
expressions of matrix-metalloproteinase (MMP)-2 andMMP-9 in rat neonatal myocytes. (A) Human
TFAM expression at 72 h in neonatal rat ventricular myocytes infected by LacZ (control)-adenovirus or
TFAM-adenovirus (multiplicity of infection [MOI] = 0.3, 1, and 3). (B) mtDNA copy number in TFAM-
adenovirus infected myocytes at 72 h after infection (1 MOI) (n = 4–5). (C) Rotenone (Rot) or DMSO (Vehicle
[Veh])-induced mitoROS detected by dihydroethidium (DHE) staining in LacZ- or TFAM-adenovirus (1 MOI)
infected myocytes. Scale bar, 100 μm (left panel). Quantification of fluorescence intensity in LacZ- or TFAM-
adenovirus (1MOI) infected myocytes (right panel; n = 3). (D) Rotenone-induced mRNA expressions of
matrix-metalloproteinase (MMP)-2 (left panel) and MMP-9 (right panel) in LacZ- or TFAM-adenovirus (1 MOI)
infected myocytes (n = 3), as measured by real-time PCR. Data are expressed as mean ± SEM. *P< 0.05,
**P< 0.01, analyzed by one-way ANOVA followed by post hoc Tukey’s test.
doi:10.1371/journal.pone.0119687.g005
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MitoROS and mitochondrial protein oxidation were suppressed in TFAM
and Twinkle mice
To further examine the effect of increased mtDNA copy number on mitoROS production in
vitro, mitochondria isolated from the hearts of TFAM and Twinkle mice were treated with an-
timycin A in the presence of the fluorescent mitoROS detection reagent, NBD-Me-TPP, which
contains triphenyl phosphonium (TPP). NBD-Me-TPP consists of major three sites, a free rad-
ical reaction site that acts as a trap for mitoROS (arrow a), fluorescent site (arrow b), and TPP
site that facilitates mitochondrial uptake (arrow c) (S3A Fig.).[20] A quencher located between
the free radical reaction and fluorescent sites is sequestered upon reacting with mitoROS to
yield a fluorescence signal. Continuous fluorescence intensity measurements displayed a linear
Fig 6. Mitochondrial reactive oxygen species (mitoROS) assay using H9c2 overexpressing human TFAM (hTFAM) or rat Twinkle-Flag (rTwinkle)
andmitochondria from TFAMmice and Twinkle (TW) mice. (A) Protein expression of hTFAM in H9c2 overexpressing hTFAM (left panel) and rTwinkle-
Flag in H9c2 overexpressing rTwinkle (right panel). (B) Quantification of mtDNA copy number in H9c2 overexpressing hTFAM and rTwinkle by real-time
PCR, (C) Antimycin A-induced mitoROS using MitoSOX probe in H9c2 overexpressing hTFAM and rTwinkle, Scale bar, 50 μm (upper panel). Quantification
of fluorescence-intensity in the cytoplasm of H9c2 cells overexpressing hTFAM or rTwinkle vs. controls (lower panel; n = 3). Data are expressed as
mean ± SEM. *P< 0.05, **P< 0.01, analyzed by one-way ANOVA followed by post hoc Tukey’s test.
doi:10.1371/journal.pone.0119687.g006
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increase in fluorescence in the presence of antimycin A (S3B Fig.), and the slope of the fluores-
cence intensity time curve was dependent on the amount of mitochondria-derived free radicals.
In accordance with the previous findings, the amount of free radicals released in mitochondria
isolated from TFAM and Twinkle mice were markedly lower compared to that of WT controls
(Fig. 7A). Nitrotyrosine (NO2-Tyr) is an oxidative modification resulting from nitration of ty-
rosine that is induced by reactive nitrogen species, and can be used as an indicator of redox in
mitochondria. As such, we examined the presence of NO2-Tyr in proteins extracts from mito-
chondria isolated from the hearts of TFAM and Twinkle mice, and found an overall reduction
of NO2-Tyr residues in TG mice compared to WT controls (Fig. 7B, arrows a, b, or c). These
results demonstrate that hTFAM or Twinkle overexpression is sufficient to limit not only
mitoROS but also the oxidation of mitochondrial proteins.
Fig 7. Nitration of mitochondrial protein and oxidizedmtDNA extracted frommitochondria of TFAMmice and Twinkle (TW) mice at 8 weeks after
creating arteriovenous fistula. (A) Fluorescence intensity rate obtained by an in vitro assay using mitochondria isolated fromWT and both transgenic mice
together with NBD-Me-TPP (n = 6). Data are expressed as mean ± SEM. *P< 0.05, **P< 0.01, analyzed by one-way ANOVA followed by post hoc Tukey’s
test. (B) Western blots of mitochondrial proteins from wild type (WT) and both transgenic (TG) mice using anti-NO2-tyrosine antibody and anti-complex II
antibody. Arrows a, b, and c identify reduced tyrosine nitration in both TGmice. Arrow d shows an additional nitrated protein (probably nitration of the
overexpressed human TFAM protein).
doi:10.1371/journal.pone.0119687.g007
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Discussion
Mitochondrial DNA is organized as a circular, closed, double-stranded DNA and encodes 13
ETC subunit proteins, 22 transfer RNAs, and two ribosomal RNAs. One mitochondrion has
multiple mtDNA copies, the depletion of which is associated with various diseases.[32] Other
research groups as well as we have shown that mtDNA depletion is associated with HF in both
humans and experimental animal models.[4,5,33,34] Using two TG mouse strains that possess
increased mtDNA copy numbers through different mechanisms, this study demonstrates that
TFAM or Twinkle overexpression increases mtDNA copy number, attenuates VO-induced ec-
centric hypertrophy and improves cardiac function, and also suppresses the production of
mitoROS and the subsequent redox-sensitive signals.
Recent studies have established the role of ROS and redox-sensitive signals in LV dilatation
during cardiac remodeling, which is accompanied by cellular alignment, myocyte elongation,
and reconstruction.[35] While mitoROS have attracted a great deal of attention in therapeutic
strategy for heart failure,[36] little is known about their effects on cardiac remodeling. In this
study, we demonstrate that MMP-2 and MMP-9—both of which have predominant roles in
the progression of VO-induced HF—were regulated by mitoROS in myocytes, and that the
overexpression of either TFAM or Twinkle suppressed their expression by limiting mitoROS.
In our current pursuit towards the clinical application of rhTFAM protein in heart failure, we
have succeeded in increasing mtDNA copy number in vivo with the administration of human
recombinant TFAM protein (rhTFAM) (S4 Fig.), emphasizing the feasibility of rhTFAM thera-
py in the future.
Despite these analyses, the mechanism of how the overexpression of TFAM or Twinkle lim-
its mitoROS remains to be elucidated. We examined the presence of major mitoROS scaveng-
ing enzymes, such as manganese superoxide dismutase (Mn-SOD), glutathione peroxidase
(GPx), and peroxiredoxin (Prx); however, no differences were observed at the gene or protein
level (S5A, B Fig.). Since the overexpression of either TFAM or Twinkle was sufficient to limit
mitoROS levels, we initially expected to see a decrease in oxidized mtDNA in both TG mice,
yet oxidized mtDNA in myocardium was increased in both TG mice after 8 weeks of VO, as
measured by real-time PCR with using 8-oxoguanine glycosylase (OGG1) (S6A Fig.). In addi-
tion, immunohistochemistry using an 8-hydroxy-2'-deoxyguanosine (8-OHdG) antibody to
detect oxidized mtDNA revealed increased cytoplasmic staining in both TG mice compared to
WT mice (S6B Fig.). Pohjoismaki et al. recently reported that the presence of 8-oxoG is directly
proportional to the amount of mtDNA in both Twinkle and WTmice.[37] Indeed, 8-oxoG per
mitochondrial protein increased in accordance with increased mtDNA copy number compared
to WT controls, as measured by Southwestern blotting (S6C Fig.). Therefore, we speculate that
mtDNA limits mitoROS by acting as a preferential substrate for ROS-mediated oxidation, sim-
ilar to the functions of mitoQ (S6D Fig.). Nevertheless, further investigation is necessary to
conclusively determine the significance of oxidized mtDNA in both TG mice. Furthermore,
Stuart et al. demonstrated that OGG-1 null mice exhibit more oxidized mtDNA without any
deterioration of mitochondrial function and cardiac function, though oxidized mtDNA is be-
lieved as harmful.[38] Our results from both TG mice also show that elevations of oxidized
mtDNA are not always accompanied with deterioration of mitochondria function and
cardiac function.
In addition, a molecular foundation for the excessive mitoROS production observed under
VO remains to be elucidated. Mitochondria-localized NADPH oxidase 4 (Nox4) was increased
significantly after 14 days but unaltered at 1 day of VO, which suggests Nox 4 might be a medi-
ator of excessive mitoROS production in myocardium during chronic VO but not in acute
phase of VO (S7 Fig.).[5] While we speculate that major cause of excessive mitoROS
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production is attributed to increased oxygen consumption in acute phase of VO, Gladden et al.
previously demonstrated that mitochondrial dysfunction, which is characterized by a reduction
of State 3 mitochondrial respiration, occurs 24 h after VO initiation.[39] Although no impair-
ments were observed in the enzymatic activities of ETC complexes after 24 h of VO in our mea-
surements (data not shown), potential alterations in mitochondrial function might cause
excessive mitoROS to elicit redox-sensitive signals during the acute phase of VO.
Conclusions
TFAM or Twinkle overexpression increases mtDNA copy number and facilitates cardioprotec-
tion associated with limited mitochondrial oxidative stress. Given that mtDNA quantity de-
creases in both HF patients and animal models, and mitoROS is one of the prospective
therapeutic targets for heart failure, our findings will provide new insights into the pathophysi-
ology in heart failure, and propose a potential therapeutic strategy targeting mtDNA and
mitoROS for heart failure.
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